417
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Modification of mood states in CKD patients: uniform manifold approximation and projection (UMAP) analysis of PANAS data

ORCID Icon & ORCID Icon
Pages 126-135 | Received 28 Mar 2022, Accepted 30 Sep 2022, Published online: 29 Oct 2022

References

  • Duncan S, Barrett LF. Affect is a form of cognition: a neurobiological analysis. Cogn Emot. 2007;21(6):1184–1211.
  • Winthorst WH, Bos EH, Roest AM, et al. Seasonality of mood and affect in a large general population sample. PLoS One. 2020;15(9):e0239033.
  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–1070.
  • Sander D. Models of emotion. In: Armony J, Vuilleumier P, editors. In: The cambridge handbook of human affective neuroscience. Cambridge: Cambridge University Press; pp. 5–54.
  • Terracciano A, McCrae RR, Costa PT. Factorial and construct validity of the Italian positive and negative affect schedule (PANAS). Eur J Psychol Assess. 2003;19(2):131–141.
  • Thompson ER. Development and validation of an internationally reliable short-form of the positive and negative affect schedule (PANAS). J Cross Cult Psychol. 2007;38:227–242.
  • Sanmartín R, Vicent M, Gonzálvez C, et al. Positive and negative affect schedule-short form: factorial invariance and optimistic and pessimistic affective profiles in Spanish children. Front Psychol. 2018;9:392.
  • Parrish BP, Zautra AJ, Davis MC. The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis. Health Psychol. 2008;27(6):694–702.
  • Cacioppo JT, Berntson GG. Relationship between attitudes and evaluative space: a critical review, with emphasis on the separability of positive and negative substrates. Psychol. Bull. 1994;115(3):401–423.
  • Watson D, Clark LA. Negative affectivity: the disposition to experience aversive emotional states. Psychol Bull. 1984;96:465–490.
  • Russell JA, Carroll JM. On the bipolarity of positive and negative affect. Psychol Bull. 1999;125(1):3–30.
  • McInnes L, Healy J, Saul N, et al. UMAP: uniform manifold approximation and projection. J Open Source Softw. 2018;3(29):861.
  • Viggiano D, Wagner CA, Blankestijn PJ, et al. Mild cognitive impairment and kidney disease: clinical aspects. Nephrol Dial Transplant. 2020;35(1):10–17.
  • Viggiano D, Wagner CA, Martino G, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16:452–469.
  • Liabeuf S, Pepin M, Franssen CFM, et al. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? Nephrol Dial Transplant. 2021;37:ii33-ii44.
  • Pépin M, Ferreira AC, Arici M, et al. Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. Nephrol Dial Transplant. 2021;37:ii23-ii32.
  • Bikbov B, Soler MJ, Pešić V, et al. Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence? Nephrol Dial Transplant. 2021;37:ii55–ii62.
  • Viggiano D, Bruchfeld A, Carriazo S, et al. Brain dysfunction in tubular and tubulointerstitial kidney diseases. Nephrol Dial Transplant. 2021;37:ii46–ii55.
  • Silva I, Unwin PH, Hoorn R, et al. Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease. Nephrol Dial Transplant. 2021;37:ii4–ii12.
  • Bobot M, Thomas L, Moyon A, et al. Uremic toxic Blood-Brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol. 2020;31(7):1509–1521.
  • Tran J, Ayers E, Verghese J, et al. Gait abnormalities and the risk of falls in CKD. Clin J Am Soc Nephrol. 2019;14(7):983–993.
  • Otobe Y, Hiraki K, Hotta C, et al. Mild cognitive impairment in older adults with pre-dialysis patients with chronic kidney disease: prevalence and association with physical function. Nephrology. 2019;24(1):50–55.
  • Sharma A, Yabes J, Al Mawed S, et al. Impact of cognitive function change on mortality in renal transplant and end-stage renal disease patients. Am J Nephrol. 2016;44(6):462–472.
  • Hernandez R, Lash JP, Burrows B, et al. The association of positive affect and cardiovascular health in hispanics/latinos with chronic kidney disease: results from the hispanic community health study/study of latinos (HCHS/SOL). Prev Med Rep. 2019;15:100916.
  • Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374(2065):20150202.
  • Viggiano D, De Santo NG, Amruthraj NJ, et al. Renal response to an oral protein load in patients with Central diabetes insipidus before and after treatment with vasopressin. J Nephrol. 2019;32:411–415.
  • Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245–265.
  • Merz EL, Malcarne VL, Roesch SC, et al. Psychometric properties of positive and negative affect schedule (PANAS) original and short forms in an African American community sample. J Affect Disord. 2013;151:942–949.